Linked Life Data

9536579

Source:http://linkedlifedata.com/resource/pubmed/id/9536579

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1998-4-23
pubmed:abstractText
To establish the precision of anticoagulant control in the first three months after mechanical heart valve replacement, 53 patients from a consecutive series of 91 were telephoned and asked to read out their anticoagulation record. The levels of international normalised ratio (INR) were analysed by Rosendaal's method. Twenty-nine per cent of patient days were spent with an INR in the recommended range of 3.0-4.5. Warfarin dosage was increased at a median INR of 2.1 (interquartile range 1.7-2.3), unchanged at 2.7 (interquartile range 2.3-3.1) and decreased at 4.3 (interquartile range 3.6-5.1). Anticoagulant control is poor in the first three months after mechanical heart valve replacement. Data on the INR at which warfarin dosage is changed suggest either that recommended guidelines are not being followed or a reluctance to increase the dosage in patients receiving inadequate anticoagulation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1368-5031
pubmed:author
pubmed:issnType
Print
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
427-9
pubmed:dateRevised
2007-2-14
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Anticoagulant control in the first three months after mechanical heart valve replacement.
pubmed:affiliation
Department of Cardiothoracic Surgery, Guy's Hospital, London, UK.
pubmed:publicationType
Journal Article